Histologic Grade Does Not Predict Outcome in Dogs with Appendicular Osteosarcoma Receiving the Standard of Care
- 28 December 2017
- journal article
- research article
- Published by SAGE Publications in Veterinary Pathology
- Vol. 55 (2) , 202-211
Abstract
Canine appendicular osteosarcoma is an aggressive bone neoplasm that imposes a short survival time. There are several published histologic grading systems for canine osteosarcoma but no universally accepted system. Location within the skeleton and therapy received are both correlated with survival time, but these factors were not always considered when the prognostic value of published grading systems was determined. Our objective was to compare 2 published histologic grading systems in a population of dogs with appendicular osteosarcoma treated with the standard of care for curative intent. Three evaluators graded 85 tumors using 2 histologic grading systems. The relationships between histologic grade as well as individual histologic features and outcome (survival time and disease-free interval) were evaluated using Kaplan-Meier survival functions and a univariate Cox proportional hazards model. Histologic grade, as assigned by any evaluator, did not correlate with outcome. Increased number of mitotic figures per 3 randomly selected 400× microscope fields, as assessed by 1 evaluator, was correlated with both survival time and disease-free interval; this was the only individual histologic feature that was significantly correlated with outcome for any evaluator. These findings cast doubt on the predictive value of routine histologic grading in dogs with appendicular osteosarcoma who receive amputation followed by adjuvant chemotherapy and highlight the need for better tools to predict outcome in canine appendicular osteosarcoma.Keywords
Funding Information
- Pet Trust
This publication has 37 references indexed in Scilit:
- Association between Absolute Tumor Burden and Serum Bone-Specific Alkaline Phosphatase in Canine Appendicular OsteosarcomaJournal of Veterinary Internal Medicine, 2013
- Prognostic factors in canine appendicular osteosarcoma – a meta-analysisBMC Veterinary Research, 2012
- Proposal of a 2-Tier Histologic Grading System for Canine Cutaneous Mast Cell Tumors to More Accurately Predict Biological BehaviorVeterinary Pathology, 2010
- Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999–2006)Journal of the American Veterinary Medical Association, 2008
- Doxorubicin and BAY 12–9566 for the Treatment of Osteosarcoma in Dogs: A Randomized, Double-Blind, Placebo-Controlled StudyJournal of Veterinary Internal Medicine, 2007
- Alternating Carboplatin and Doxorubicin as Adjunctive Chemotherapy to Amputation or Limb-Sparing Surgery in the Treatment of Appendicular Osteosarcoma in DogsJournal of Veterinary Internal Medicine, 2004
- Interobserver Variability Among Expert Orthopedic Pathologists for Diagnosis, Histologic Grade, and Determination of the Necessity for Chemotherapy in OsteosarcomaFetal and Pediatric Pathology, 2000
- Amputation and Carboplatin for Treatment of Dogs With Osteosarcoma: 48 Cases (1991 to 1993)Journal of Veterinary Internal Medicine, 1996
- Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II studyInternational Journal of Hyperthermia, 1992
- Canine OsteosarcomaJournal of Veterinary Internal Medicine, 1988